Uncategorized
VIDEO: Allegro preps to move into phase 3 trial with DME treatment
NEWPORT BEACH, Calif. — Vicken Karageozian, MD, president and chief medical officer for Allegro Pharmaceuticals, discusses the progress of the company’s product Luminate, which is moving into phase 3 trials for the treatment of diabetic macular edema.